Gericke N200 Nibbler Provides Size Reduction - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gericke N200 Nibbler Provides Size Reduction


Pharmaceutical Technology
Volume 38, Issue 1, pp. 16
The N200 Pharma Nibbler offers a 200 mm diameter inlet and throughput of 1.500 (1/h), providing an alternative to hammer mills and more complex equipment for consistent size reduction of materials and agglomerates found in pharmaceutical production. Products enter the inlet either by a dump or controlled feed where a paddle assembly then rotates the product inside the size reduction chamber at a slow rotational speed. Attrition milling shears the product through the screen where it is discharged through the single outlet. The N200 Nibbler model features high capacity size reduction, a compact design, low power consumption and noise levels, minimum product temperature rise and fines generation, consistent particle size, and low rotational speed. It is suitable for glove box mounting and offers easy basket removal to provide improved access for cleaning.

Powder Technologies

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here